Rapid Micro Biosystems (NASDAQ:RPID) CEO Sells $149,092.03 in Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Robert Jr. Spignesi sold 38,327 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $3.89, for a total value of $149,092.03. Following the transaction, the chief executive officer owned 1,187,770 shares in the company, valued at $4,620,425.30. This represents a 3.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Rapid Micro Biosystems Stock Down 2.0%

RPID opened at $3.89 on Monday. The company has a market capitalization of $172.40 million, a P/E ratio of -3.85 and a beta of 1.38. The company has a debt-to-equity ratio of 0.42, a current ratio of 4.23 and a quick ratio of 2.95. The firm’s fifty day moving average price is $3.67 and its two-hundred day moving average price is $3.41. Rapid Micro Biosystems, Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $4.94.

Hedge Funds Weigh In On Rapid Micro Biosystems

Several hedge funds have recently added to or reduced their stakes in RPID. Evernest Financial Advisors LLC increased its stake in Rapid Micro Biosystems by 355.1% in the third quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company’s stock valued at $669,000 after purchasing an additional 156,234 shares in the last quarter. 683 Capital Management LLC bought a new stake in shares of Rapid Micro Biosystems in the 4th quarter valued at $350,000. Millennium Management LLC bought a new stake in shares of Rapid Micro Biosystems in the 4th quarter valued at $338,000. Informed Momentum Co LLC acquired a new stake in Rapid Micro Biosystems during the 4th quarter worth $224,000. Finally, Jane Street Group LLC lifted its holdings in Rapid Micro Biosystems by 176.1% during the fourth quarter. Jane Street Group LLC now owns 105,301 shares of the company’s stock worth $305,000 after acquiring an additional 67,161 shares in the last quarter. Institutional investors and hedge funds own 52.60% of the company’s stock.

Analyst Ratings Changes

RPID has been the subject of several research analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, January 22nd. Wall Street Zen raised Rapid Micro Biosystems from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $8.00.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.